FindTrial
Sign In

Pruritus in Patients With Chronic Kidney Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01727180
Enrollment
108
Registered
2012-11-15
Start date
2011-06-30
Completion date
2013-12-31
Last updated
2015-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure, Chronic, Pruritus

Brief summary

We believe that knowing characteristics of uremic pruritus is the foundation to investigate its pathophysiology and offer better skin care for patients with chronic kidney disease. We therefore conducted this cross-sectional study to evaluate the characteristics of uraemic pruritus.

Interventions

OTHERQuestionnaire based on the McGill Pain Questionnaire

Interview questionnaire based on the short form of the McGill Pain Questionnaire

Sponsors

Far Eastern Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults older than 20 years old, with CKD stage 3 to 5D, with symptoms of pruritus.

Exclusion criteria

* Patients who refused to answer the questionnaire or unable to understand the contents of the questionnaire.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS)Once at the entry of the studyA visual analog scale (VAS) measuring the general severity of pruritus was reported from 0 to 10 (0 = no pruritus, 10 = worst pruritus imaginable

Countries

Taiwan

Participant flow

Participants by arm

ArmCount
Chronic Kidney Disease
Questionnaire based on the McGill Pain Questionnaire: Interview questionnaire based on the short form of the McGill Pain Questionnaire
108
Total108

Baseline characteristics

CharacteristicChronic Kidney Disease
Age, Continuous61.1 years
STANDARD_DEVIATION 12.9
Sex: Female, Male
Female
55 Participants
Sex: Female, Male
Male
53 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 108
serious
Total, serious adverse events
0 / 108

Outcome results

Primary

Visual Analog Scale (VAS)

A visual analog scale (VAS) measuring the general severity of pruritus was reported from 0 to 10 (0 = no pruritus, 10 = worst pruritus imaginable

Time frame: Once at the entry of the study

ArmMeasureValue (MEAN)Dispersion
Chronic Kidney DiseaseVisual Analog Scale (VAS)3.35 units on a scaleStandard Deviation 2.27

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026